Pediatric Exclusivity: How the FDA Extends Market Protection for Drugs Without Changing Patents
March 13, 2026 by Maxwell Harrington
Pediatric exclusivity gives drugmakers six extra months of market protection by delaying generic approval - even after patents expire. It's not a patent extension, but it works even better. Here's how the FDA makes it happen.